Most Recent Articles by Laurel Ranger
Functional improvement was evaluated for individuals with psychotic disorders who underwent a 24-session social cognitive skills training program.
After a median of 25 years of follow-up, 2.4% of those born to a parent with a type 1 diabetes diagnosis were diagnosed with ADHD, compared with only 1.5% of the matched controls.
Although all-cause pharmacy costs were higher in the paliperidone palmitate group, adjusted all-cause medical costs were lower.
The new guideline focuses on evidence-based pharmacologic treatments in alcohol use disorder and includes recommendations about naltrexone, acamprosate, disulfiram, topiramate, and gabapentin.
These results indicate the need for thorough preoperative psychiatric history assessment in patients considering bariatric surgery, as well as postoperative surveillance.
More Articles by Laurel Ranger
Sign Up for Free e-newsletters
Psychiatry Advisor Articles
- Amisulpride May Be Most Effective Antipsychotic for Negative Symptoms in Schizophrenia
- Frustrations With Prior Authorization: A Thorn in the Side of Clinicians
- Efficacy of Drugs for Psychosis, Relapse Prevention for Bipolar Depression, Mania
- No Evidence of Cognitive Impairment With Lisdexamfetamine Dimesylate in ADHD
- Plasma Autoantibodies Possible Biomarker for Schizophrenia
- Substance-Induced Psychosis Associated With Development of Schizophrenia, Bipolar Disorder
- Neuropsychiatric Events May Be Linked to Nitrated Nucleosome Levels in Lupus
- New APA Guideline Recommendation for Treatment of Alcohol Use Disorder
- Reducing PTSD Symptoms: Propranolol Before Reactivation Therapy
- Cannabis Use Associated With Subsequent Psychotic Experiences in Adolescents
- Cognitive Enhancement Therapy Beneficial for Neurocognitive Function in Autism
- The Crisis of Physician Suicides: Past and Present
- Affective Temperaments in Bipolar Have a Significant Impact on Functional, Clinical Outcomes of Mania
- Ketamine: A Promising Agent for Managing Treatment-Resistant Depression
- Patterns of Healthcare Use Before Diagnosis of Psychotic Disorders in Young Adults